Skip to main content
. 2022 Dec 13;14(24):6137. doi: 10.3390/cancers14246137

Figure 4.

Figure 4

Figure 4

Effects of docetaxel (DTX) vs. LNPDTX-P on in vivo tumour tissues. (A) Amounts of gold nanoparticles (GNPs) per gram of tumour tissue in untreated tissues, tissues treated with free DTX, tissues treated with LNPDTX-1, and tissues treated with LNPDTX-2 over time. ** indicates p < 0.01, *** indicates p < 0.001. (B) Cell cycle assay for untreated tumour tissue, tissue treated with free DTX, tissue treated with LNPDTX-1, and tissue treated with LNPDTX-2 over time. (C) Darkfield images of 4 µm sections of untreated tumour tissues, tissues treated with free DTX, and tissues treated with LNPDTX-1. Scale bar: 40 µm. (D) Treatment of MIA PaCa-2 subcutaneous tumour with free docetaxel (DTX) vs. LNPDTX-P. Hematoxylin and eosin stained sections of tumour tissues 0 h, 24 h, and 48 h after dosing with the drugs and GNPs. Scale bar: 80 µm.